Edwards Lifesciences Corporation (EW)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 88.01 |
| Open | 87.00 |
| Bid | 85.29 x 800 |
| Ask | 87.20 x 800 |
| Day's range | 84.71 - 88.38 |
| 52-week range | 60.57 - 96.12 |
| Volume | |
| Avg. volume | 4,007,522 |
| Market cap | 52.025B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 37.58 |
| EPS (TTM) | 2.30 |
| Earnings date | 24 Jul 2024 - 29 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 94.40 |
Investor's Business DailyThis 'Critical' Business Helped Edwards Lifesciences Offset Its TAVR Miss
Edwards Lifesciences stock underperformed its peers on Friday, sliding on light sales of its transcatheter aortic heart-valve replacements.
ZacksFactors Setting the Tone For Lantheus' (LNTH) Q1 Earnings
Lantheus' (LNTH) first-quarter results are likely to reflect solid top-line performance on the back of robust product adoption.
ZacksEdwards Lifesciences (EW) Q1 Earnings Top, 2024 Sales View Up
Strong performance of SAPIEN 3 Ultra RESILIA platform and sustainable TAVR growth drives Edwards Lifesciences (EW) Q1 revenues.
© 2024 Yahoo. All rights reserved.